LCN2 and neoplasm: In addition, lipocalin 2 knockout mice (Lcn2-KO) had reduced ATGL expression in iWAT compared to tumor-loaded WT mice, as well as reduced expression of the myasthenic molecular markers MuRF-1 and Atrogin1.70